Kids Library Home

Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

Available items only
Book Cover
Author Carreyrou, John, author.

Title Bad blood : secrets and lies in a Silicon Valley startup / John Carreyrou.

Publication Info. New York : Alfred A. Knopf, 2018.


Location Call No. Status
 GDL Casa Verdugo Library Non-Fiction    338.7681 CAR    Available
 GDL Central Library Non-Fiction    338.7681 CAR    Available
 GDL Central Library Non-Fiction    338.7681 CAR    DUE 03-01-21 Billed
 GDL Central Library Non-Fiction    338.7681 CAR    Available
1 copy being processed for GDL Central Library Non-Fiction.
2 copies being processed for GDL Central Library Non-Fiction.
2 copies being processed for GDL Central Library Non-Fiction.
Edition First edition.
Description x, 339 pages ; 25 cm
text txt rdacontent
unmediated n rdamedia
volume nc rdacarrier
Gender group: gdr Men lcdgt
Occupational/field of activity group: occ Journalists lcdgt
Nationality/regional group: nat New Yorkers (New York State) lcdgt
Nationality/regional group: nat Americans lcdgt
Bibliography Includes bibliographical references (pages 305-324) and index.
Contents A purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes.
Summary In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When the author, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both the author and the newspaper were threatened with lawsuits. Undaunted, the paper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.--adapted from publisher's description.
Subject Holmes, Elizabeth, 1984-
Theranos (Firm) -- History.
Hematologic equipment industry -- United States.
New business enterprises -- Corrupt practices -- United States -- Cases.
Securities fraud -- United States -- Cases.
Added Title Secrets and lies in a Silicon Valley startup
ISBN 9781524731656 (hardcover)
152473165X (hardcover)
9781524731663 (ebook)
9781524711481 (open market)
Standard No. 99977268312

Available items only